Managers / Q1 2024 · view latest →
QSV Equity Investors LLC
CIK 0002011250 · 377 E. BUTTERFIELD RD, SUITE 220, LOMBARD, IL, 60148 · 844-322-5527
Summary
Qsv Equity Investors LLC reported $104M in U.S.-listed holdings across 90 positions for Q1 2024.
Its largest position, MEDP, represents 2.4% of the portfolio.
Compared with Q4 2023, the fund opened 7 new positions and exited 6.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 88.5% · $92M
- REIT · 7.8% · $8M
- Other · 3.1% · $3M
- ETP · 0.4% · $458,760
- Closed-End Fund · 0.1% · $144,708
Quarter-over-Quarter Changes full breakdown →
vs Q4 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VSTSVESTIS CORPORATION | NEW | +75.1K | 75.1K | +$1M | $1M |
| ASTHASTRANA HEALTH INC | NEW | +29.6K | 29.6K | +$1M | $1M |
| CPAYCORPAY INC | NEW | +1.5K | 1.5K | +$454,977 | $454,977 |
| OTISOTIS WORLDWIDE CORP | NEW | +3.8K | 3.8K | +$373,950 | $373,950 |
| MTCHMATCH GROUP INC NEW | NEW | +8.4K | 8.4K | +$306,457 | $306,457 |
| LECOLINCOLN ELEC HLDGS INC | NEW | +899 | 899 | +$229,641 | $229,641 |
| ICLRICON PLC | NEW | +678 | 678 | +$227,774 | $227,774 |
| MGPIMGP INGREDIENTS INC NEW | SOLD OUT | −12.9K | 0 | −$1M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2025 | $68M | 89 | Feb 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $98M | 92 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $96M | 90 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $97M | 87 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $104M | 85 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $107M | 87 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $96M | 80 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $104M | 90 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $103M | 89 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.